Source: FDA, National Drug Code (US) Revision Year: 2019
Technescan HDP is supplied as a lyophilized powder, packaged under nitrogen in vials for intravenous administration after reconstitution with ADDITIVE-FREE sodium pertechnetate Tc 99m. Each vial contains 3.15 mg oxidronate sodium and 0.258 mg, minimum, stannous chloride (SnCl2•2H2O), 0.297 mg, theoretical, stannous chloride (SnCl2•2H2O) with 0.343 mg, maximum, tin chloride [stannous and stannic] dihydrate as SnCl2•2H2O as active ingredients. In addition, each vial contains 0.84 mg gentisic acid as a stabilizer and 30.0 mg sodium chloride. The pH is adjusted with hydrochloric acid and/or sodium hydroxide. The pH of the reconstituted drug is between 4.0 and 5.5. The contents of the vial are sterile and non-pyrogenic.
The chemical structure of oxidronate sodium is:
This radiopharmaceutical diagnostic agent, when reconstituted with ADDITIVE-FREE sodium pertechnetate Tc 99m forms a complex of unknown structure.
Technetium Tc 99m decays by isomeric transition with a physical half-life of 6.02 hours.1 The principal photon that is useful for detection and imaging is listed in Table 1.
Table 1. Principal Radiation Emission Data1:
Radiation | Mean Percent/ Disintegration | Energy (keV) |
---|---|---|
Gamma-2 | 89.07 | 140.5 |
1 Kocher, David C., “Radioactive Decay Data Tables,” DOE/TIC-11026, 108, (1981).
The specific gamma ray constant for Technetium Tc 99m is 0.78 R/mCi-hr at 1 cm. The first half-value thickness of lead (Pb) for Technetium Tc 99m is 0.017 cm. A range of values for the relative attenuation of the radiation emitted by this radionuclide that results from interposition of various thicknesses of Pb is shown in Table 2. For example, the use of 0.25 cm of Pb will decrease the external radiation exposure by a factor of about 1000.
Table 2. Radiation Attenuation by Lead Shielding:
Shield Thickness (Pb) cm | Coefficient of Attenuation |
---|---|
0.017 | 0.5 |
0.08 | 10 -1 |
0.16 | 10 -2 |
0.25 | 10 -3 |
0.33 | 10 -4 |
To correct for physical decay of this radionuclide, the fractions that remain at selected time intervals after the time of calibration are shown in Table 3.
Table 3. Physical Decay Chart: Technetium Tc 99m Half-Life 6.02 Hours:
Hours | FractionRemaining | Hours | FractionRemaining |
---|---|---|---|
0* | 1.000 | 7 | 0.447 |
1 | 0.891 | 8 | 0.398 |
2 | 0.794 | 9 | 0.355 |
3 | 0.708 | 10 | 0.316 |
4 | 0.631 | 11 | 0.282 |
5 | 0.562 | 12 | 0.251 |
6 | 0.501 |
* Calibration time
How Supplied |
---|
Technescan HDP is supplied as a lyophilized powder packaged in vials. Each vial contains 3.15 mg oxidronate sodium and 0.258 mg, minimum, stannous chloride (SnCl2•2H2O), 0.297 mg, theoretical, stannous chloride (SnCl2•2H2O) with 0.343 mg, maximum, tin chloride [stannous and stannic] dihydrate as SnCl2•2H2O. In addition, each vial contains 0.84 mg gentisic acid as a stabilizer and 30.0 mg sodium chloride. Kits containing 5 vials (NDC 69945-091-20) or 30 vials (NDC 69945-091-40) are available. The drug can be stored at controlled room temperature 20° to 25°C (68° to 77°F) both prior to and following reconstitution with ADDITIVE-FREE sodium pertechnetate Tc 99m. This reagent kit is approved for distribution to persons licensed by the U.S. Nuclear Regulatory Commission to use byproduct material identified in Section 35.200 or under an equivalent license of an Agreement State. Manufactured by: Curium US LLC, 2703 Wagner Place, Maryland Heights, MO 63043 USA |
Drug | Countries | |
---|---|---|
TECHNESCAN HDP | Austria, Estonia, Spain, France, Hong Kong, Ireland, Romania, Singapore, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.